Profile
Keith S.
Ehrlich worked as an Auditor at Coopers & Lybrand LLP from 1980 to 1991.
He then worked as Treasurer & Finance Director at Vertex Pharmaceuticals, Inc. from 1991 to 1993, followed by CFO, Treasurer, VP-Finance & Administration at OraVax, Inc. from 1993 to 1998.
He then worked as CFO, Treasurer, SVP-Finance & Administration at Dyax Corp.
in 1998 and CFO, Vice President-Finance & Administration at Argentys Corp.
from 1999 to 2003.
He joined Synta Pharmaceuticals Corp.
in 2004 and worked as CFO, Vice President-Finance & Administration until 2014.
From 2015 to 2017, he worked as CFO & Principal Accounting Officer at AVEO Pharmaceuticals, Inc. Mr. Ehrlich received his undergraduate degree from Drew University and his MBA from Rutgers State University of New Jersey.
Former positions of Keith S. Ehrlich
| Companies | Position | End |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Director of Finance/CFO | 2017-05-31 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Director of Finance/CFO | 2014-12-07 |
Argentys Corp.
Argentys Corp. Packaged SoftwareTechnology Services Develops and provides scientific computational software solutions | Director of Finance/CFO | 2003-03-31 |
| DYAX CORP. | Director of Finance/CFO | 1999-06-30 |
OraVax, Inc.
OraVax, Inc. BiotechnologyHealth Technology Develops oral vaccines and non injected antibody products | Director of Finance/CFO | 1997-12-31 |
Training of Keith S. Ehrlich
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Drew University
Drew University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
OraVax, Inc.
OraVax, Inc. BiotechnologyHealth Technology Develops oral vaccines and non injected antibody products | Health Technology |
Dyax Corp.
Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Health Technology |
Coopers & Lybrand LLP
Coopers & Lybrand LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Argentys Corp.
Argentys Corp. Packaged SoftwareTechnology Services Develops and provides scientific computational software solutions | Technology Services |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
- Stock Market
- Insiders
- Keith S. Ehrlich
















